Significant Improvement of Prognosis After the Advent of Immune Checkpoint Inhibitors in Patients with Advanced, Unresectable, or Metastatic Urothelial Carcinoma: A Propensity Score Matching and Inverse Probability of Treatment Weighting Analysis on Real-World Data.
Makito MiyakeNobutaka NishimuraTakuto ShimizuMikiko OhnishiMasaomi KuwadaYoshitaka ItamiTakeshi InoueKenta OhnishiYoshihiro MatsumotoTakanori YoshidaYoshihiro TatsumiMasatake ShinoharaShunta HoriYosuke MorizawaDaisuke GotohYasushi NakaiSatoshi AnaiKazumasa TorimotoKatsuya AokiTomomi FujiiNobumichi TanakaKiyohide FujimotoPublished in: Cancer management and research (2022)
We demonstrated a significant improvement in prognosis after the advent of pembrolizumab for patients with aUC. ICIs should not be restricted based on patient characteristics.